Some GLP-1 sellers try to trick you into thinking you’re getting the brand-name drug — meaning Ozempic, Wegovy, Mounjaro, or Zepbound — or try to convince you the product they sell is a generic version of those drugs. There are no approved generic versions available. One report found that one-third of websites that sell their own versions of the brand-name drugs implied that the products were the same as the FDA-approved ones.
These marketing claims are not necessarily illegal, but suppliers engaging in this type of misleading advertising may be less likely to adequately inform their customers about potential risks and side effects. And some sellers have gone further, claiming that their products are even more effective than those approved by the FDA.
Other websites publish unfounded health claims. Semaglutide and tirzepatide are only approved for the treatment of a certain number of conditions: obesity and overweight, type 2 diabetes, sleep apnea, and cardiovascular disease. If the website claims it can help you live longer, cure substance abuse, or any other health claim that seems too good to be true, you should be raising an eyebrow.
Read the full article here
